6.
Levin A, Jylhava J, Religa D, Shallcross L
. COVID-19 prevalence and mortality in longer-term care facilities. Eur J Epidemiol. 2022; 37(3):227-234.
PMC: 8994824.
DOI: 10.1007/s10654-022-00861-w.
View
7.
Faucher B, Assab R, Roux J, Levy-Bruhl D, Tran Kiem C, Cauchemez S
. Agent-based modelling of reactive vaccination of workplaces and schools against COVID-19. Nat Commun. 2022; 13(1):1414.
PMC: 8931017.
DOI: 10.1038/s41467-022-29015-y.
View
8.
Saadi N, Chi Y, Ghosh S, Eggo R, McCarthy C, Quaife M
. Models of COVID-19 vaccine prioritisation: a systematic literature search and narrative review. BMC Med. 2021; 19(1):318.
PMC: 8632563.
DOI: 10.1186/s12916-021-02190-3.
View
9.
Tuite A, Fisman D, Kwong J, Greer A
. Optimal pandemic influenza vaccine allocation strategies for the Canadian population. PLoS One. 2010; 5(5):e10520.
PMC: 2865540.
DOI: 10.1371/journal.pone.0010520.
View
10.
Lopez Bernal J, Andrews N, Gower C, Gallagher E, Simmons R, Thelwall S
. Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant. N Engl J Med. 2021; 385(7):585-594.
PMC: 8314739.
DOI: 10.1056/NEJMoa2108891.
View
11.
Lemaitre J, Pasetto D, Zanon M, Bertuzzo E, Mari L, Miccoli S
. Optimal control of the spatial allocation of COVID-19 vaccines: Italy as a case study. PLoS Comput Biol. 2022; 18(7):e1010237.
PMC: 9299324.
DOI: 10.1371/journal.pcbi.1010237.
View
12.
Nanduri S, Pilishvili T, Derado G, Soe M, Dollard P, Wu H
. Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March.... MMWR Morb Mortal Wkly Rep. 2021; 70(34):1163-1166.
PMC: 8389386.
DOI: 10.15585/mmwr.mm7034e3.
View
13.
Yang H
. The basic reproduction number obtained from Jacobian and next generation matrices - A case study of dengue transmission modelling. Biosystems. 2014; 126:52-75.
DOI: 10.1016/j.biosystems.2014.10.002.
View
14.
Buckner J, Chowell G, Springborn M
. Dynamic prioritization of COVID-19 vaccines when social distancing is limited for essential workers. Proc Natl Acad Sci U S A. 2021; 118(16).
PMC: 8072365.
DOI: 10.1073/pnas.2025786118.
View
15.
Abu-Raddad L, Chemaitelly H, Butt A
. Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants. N Engl J Med. 2021; 385(2):187-189.
PMC: 8117967.
DOI: 10.1056/NEJMc2104974.
View
16.
Asano E, Gross L, Lenhart S, Real L
. Optimal control of vaccine distribution in a rabies metapopulation model. Math Biosci Eng. 2008; 5(2):219-38.
DOI: 10.3934/mbe.2008.5.219.
View
17.
Vieira C, Franco O, Gomez Restrepo C, Abel T
. COVID-19: The forgotten priorities of the pandemic. Maturitas. 2020; 136:38-41.
PMC: 7195319.
DOI: 10.1016/j.maturitas.2020.04.004.
View
18.
Zhou S, Zhou S, Zheng Z, Lu J
. Optimizing Spatial Allocation of COVID-19 Vaccine by Agent-Based Spatiotemporal Simulations. Geohealth. 2021; 5(6):e2021GH000427.
PMC: 8207830.
DOI: 10.1029/2021GH000427.
View
19.
Bubar K, Reinholt K, Kissler S, Lipsitch M, Cobey S, Grad Y
. Model-informed COVID-19 vaccine prioritization strategies by age and serostatus. Science. 2021; 371(6532):916-921.
PMC: 7963218.
DOI: 10.1126/science.abe6959.
View
20.
Tejada-Vera B, Kramarow E
. COVID-19 Mortality in Adults Aged 65 and Over: United States, 2020. NCHS Data Brief. 2022; (446):1-8.
View